B-type natriuretic peptide shows a graded association with decline in kidney function in individuals with diabetes, even at concentrations ≤ 18.4 pg/mL, which are conventionally considered normal.
Incidence patterns of STEMI and NSTEMI in type 1 diabetes depend on age, vascular history, and kidney function, a Finnish ...
This week, the FDA flexed its regulatory authority to approve the first medicine to treat focal segmental glomerulosclerosis, ...
Chronic kidney disease (CKD) affects nearly 36 million people. “CKD is a real public health crisis, and one that’s steadily rising,” said Merlin Thomas, M.B.Ch.B., Ph.D., FRACP, a professor of ...
The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and ...
A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...
A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to ...
The human body can survive weeks without food, but only days without water. Yet millions of people walk around in a state of chronic dehydration, completely unaware that their kidneys are slowly ...
Jacqueline Garonzik Wang, M.D. As kidney transplant wait times continue to grow nationwide, the University of Alabama at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results